NHS data lays bare Britain’s child obesity crisis - with kids as young as four treated for severe obesity because they weigh ...
As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by BrightGene Bio-Medical (688166.SH) for BGM0504 has reignited market attention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results